Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
---|---|---|---|---|---|---|
Q3 2020 | 26 | 53,792 | WFC, CVX, T, GSK | 13F-HR | 11/16/2020 | 000110465920125935 |
Q2 2020 | 10 | 56,039 | WFC, CVX, T, GSK | 13F-HR | 8/14/2020 | 000110465920095329 |
Q1 2020 | 11 | 58,266 | WFC, CVX, T, GSK | 13F-HR | 5/15/2020 | 000110465920062381 |
Q4 2019 | 14 | 130,137 | WFC, CVX, T, TGT | 13F-HR | 2/6/2020 | 000110465920011799 |
Q3 2019 | 13 | 115,622 | WFC, CVX, T, VOD | 13F-HR | 11/14/2019 | 000110465919064143 |
Q2 2019 | 12 | 117,110 | WFC, CVX, T, GSK | 13F-HR | 8/14/2019 | 000114420419040029 |
Q1 2019 | 13 | 96,848 | WFC, CVX, AAPL, T | 13F-HR | 5/15/2019 | 000114420419026373 |
Q4 2018 | 28 | 95,702 | WFC, CVX, T, GSK | 13F-HR | 2/20/2019 | 000114420419008953 |
Q3 2018 | 37 | 108,861 | WFC, CVX, T, GSK | 13F-HR | 12/6/2018 | 000114420418063345 |
Q2 2018 | 41 | 107,409 | WFC, CVX, GSK, T | 13F-HR | 8/20/2018 | 000114420418045559 |
Q1 2018 | 41 | 99,958 | WFC, CVX, GSK, VOD | 13F-HR | 5/14/2018 | 000114420418028209 |
Q4 2017 | 43 | 108,276 | WFC, CVX, VZ, TGT | 13F-HR | 1/29/2018 | 000114420418004174 |